Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicles in people with alopecia have lower levels of a key blood vessel growth protein.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Substance P may worsen acne by increasing inflammation, but corticosteroids might help by reducing this effect.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Organotypic culture systems can grow skin tissues that mimic real skin functions and are useful for skin disease and hair growth research, but they don't fully replicate skin complexity.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

A special hydrogel helps heal skin without scars and regrows hair.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Prolactin may be important for skin growth and immune function.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Minoxidil affects cell growth in two ways: low doses increase growth, while high doses slow it down and can be toxic.

COVID-19 infection may trigger alopecia areata in some patients.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

Safflower has been used in traditional medicine for centuries and shows promise in treating heart, brain, and inflammatory conditions, but more research is needed to ensure its safety.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Cavity macrophages gather on organ surfaces but don't really invade or help repair the organs after injury.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.